April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Robert Z. Orlowski: Myeloma Paper of the Day
Feb 14, 2024, 13:50

Robert Z. Orlowski: Myeloma Paper of the Day

Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, posted on X/Twitter:

Myeloma Paper of the Day: Matching-adjusted indirect comparison of efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma suggests that elranatamab may have better ORR and CR rates, and better PFS and OS.”

 

Image

View additional information.
Source: Robert Z. Orlowski/X